400 related articles for article (PubMed ID: 15300592)
1. KLF11 mediates a critical mechanism in TGF-beta signaling that is inactivated by Erk-MAPK in pancreatic cancer cells.
Ellenrieder V; Buck A; Harth A; Jungert K; Buchholz M; Adler G; Urrutia R; Gress TM
Gastroenterology; 2004 Aug; 127(2):607-20. PubMed ID: 15300592
[TBL] [Abstract][Full Text] [Related]
2. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
[TBL] [Abstract][Full Text] [Related]
3. Involvement of MAP kinase cascades in Smad7 transcriptional regulation.
Uchida K; Suzuki H; Ohashi T; Nitta K; Yumura W; Nihei H
Biochem Biophys Res Commun; 2001 Nov; 289(2):376-81. PubMed ID: 11716483
[TBL] [Abstract][Full Text] [Related]
4. Tieg3/Klf11 induces apoptosis in OLI-neu cells and enhances the TGF-beta signaling pathway by transcriptional repression of Smad7.
Gohla G; Krieglstein K; Spittau B
J Cell Biochem; 2008 Jun; 104(3):850-61. PubMed ID: 18189266
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NKX2.1 and HNF-3 transcription factors.
Li C; Zhu NL; Tan RC; Ballard PL; Derynck R; Minoo P
J Biol Chem; 2002 Oct; 277(41):38399-408. PubMed ID: 12161428
[TBL] [Abstract][Full Text] [Related]
6. Smad7 abrogates transforming growth factor-beta1-mediated growth inhibition in COLO-357 cells through functional inactivation of the retinoblastoma protein.
Boyer Arnold N; Korc M
J Biol Chem; 2005 Jun; 280(23):21858-66. PubMed ID: 15811853
[TBL] [Abstract][Full Text] [Related]
7. The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer.
Kleeff J; Ishiwata T; Maruyama H; Friess H; Truong P; Büchler MW; Falb D; Korc M
Oncogene; 1999 Sep; 18(39):5363-72. PubMed ID: 10498890
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3.
Edlund S; Bu S; Schuster N; Aspenström P; Heuchel R; Heldin NE; ten Dijke P; Heldin CH; Landström M
Mol Biol Cell; 2003 Feb; 14(2):529-44. PubMed ID: 12589052
[TBL] [Abstract][Full Text] [Related]
9. CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC.
Chen Y; Blom IE; Sa S; Goldschmeding R; Abraham DJ; Leask A
Kidney Int; 2002 Oct; 62(4):1149-59. PubMed ID: 12234285
[TBL] [Abstract][Full Text] [Related]
10. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling.
Hanyu A; Ishidou Y; Ebisawa T; Shimanuki T; Imamura T; Miyazono K
J Cell Biol; 2001 Dec; 155(6):1017-27. PubMed ID: 11739411
[TBL] [Abstract][Full Text] [Related]
11. HER2/Neu- and TAK1-mediated up-regulation of the transforming growth factor beta inhibitor Smad7 via the ETS protein ER81.
Dowdy SC; Mariani A; Janknecht R
J Biol Chem; 2003 Nov; 278(45):44377-84. PubMed ID: 12947087
[TBL] [Abstract][Full Text] [Related]
12. Smad7 is a TGF-beta-inducible attenuator of Smad2/3-mediated inhibition of embryonic lung morphogenesis.
Zhao J; Crowe DL; Castillo C; Wuenschell C; Chai Y; Warburton D
Mech Dev; 2000 May; 93(1-2):71-81. PubMed ID: 10781941
[TBL] [Abstract][Full Text] [Related]
13. Smad4 mediates activation of mitogen-activated protein kinases by TGF-beta in pancreatic acinar cells.
Simeone DM; Zhang L; Graziano K; Nicke B; Pham T; Schaefer C; Logsdon CD
Am J Physiol Cell Physiol; 2001 Jul; 281(1):C311-9. PubMed ID: 11401854
[TBL] [Abstract][Full Text] [Related]
14. Cross-talk between the p42/p44 MAP kinase and Smad pathways in transforming growth factor beta 1-induced furin gene transactivation.
Blanchette F; Rivard N; Rudd P; Grondin F; Attisano L; Dubois CM
J Biol Chem; 2001 Sep; 276(36):33986-94. PubMed ID: 11448947
[TBL] [Abstract][Full Text] [Related]
15. Smad7 induces tumorigenicity by blocking TGF-beta-induced growth inhibition and apoptosis.
Halder SK; Beauchamp RD; Datta PK
Exp Cell Res; 2005 Jul; 307(1):231-46. PubMed ID: 15922743
[TBL] [Abstract][Full Text] [Related]
16. c-Jun interacts with the corepressor TG-interacting factor (TGIF) to suppress Smad2 transcriptional activity.
Pessah M; Prunier C; Marais J; Ferrand N; Mazars A; Lallemand F; Gauthier JM; Atfi A
Proc Natl Acad Sci U S A; 2001 May; 98(11):6198-203. PubMed ID: 11371641
[TBL] [Abstract][Full Text] [Related]
17. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
18. Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-beta in pancreatic tumor cells.
Chen WB; Lenschow W; Tiede K; Fischer JW; Kalthoff H; Ungefroren H
J Biol Chem; 2002 Sep; 277(39):36118-28. PubMed ID: 12140283
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor β and Ras/MEK/ERK signaling regulate the expression level of a novel tumor suppressor Lefty.
Miyata N; Azuma T; Hozawa S; Higuchi H; Yokoyama A; Kabashima A; Igarashi T; Saeki K; Hibi T
Pancreas; 2012 Jul; 41(5):745-52. PubMed ID: 22441145
[TBL] [Abstract][Full Text] [Related]
20. Repression of bone morphogenetic protein and activin-inducible transcription by Evi-1.
Alliston T; Ko TC; Cao Y; Liang YY; Feng XH; Chang C; Derynck R
J Biol Chem; 2005 Jun; 280(25):24227-37. PubMed ID: 15849193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
